Related Experiment Video
Updated: Feb 18, 2026

Immunometabolic Circuits in Infection for Advancing Host Directed Therapies
Published on: September 13, 2024
Immunotherapy treatment: an issue for metabolic response
Luca Tagliabue1, Antonella Capozza2, Claudio Maioli3
1Unit of Nuclear Medicine, Department of Diagnostic Services, San Paolo University Hospital, ASST Santi Paolo e Carlo, Milan, Italy - luca.tagliabue@asst-santipaolocarlo.it.
Immunotherapy improves cancer survival, but evaluating treatment response is challenging. New criteria are needed to distinguish true progression from pseudo-progression during immune-based cancer therapies.
Area of Science:
- Oncology
- Immunology
- Radiology
Background:
- Immunotherapy has emerged as a vital cancer treatment, enhancing progression-free and overall survival for various malignancies.
- Despite its success, challenges remain in evaluating treatment response due to the emergence of new drugs and limited clinical experience.
Purpose of the Study:
- To review current evidence on immunotherapy response evaluation in cancer.
- To address the complexities of pseudo-progression and its distinction from disease progression under immunotherapy.
Main Methods:
- Analysis of existing literature on cancer immunotherapy response.
- Review of radiological and nuclear medicine criteria for assessing treatment efficacy.
Main Results:
- Immunotherapy offers significant survival benefits but requires careful response assessment.
- Pseudo-progression, characterized by lesion changes and new lesions, can mimic disease progression but may precede regression.
Conclusions:
- Accurate evaluation of immunotherapy response is crucial for optimal patient management.
- Distinguishing pseudo-progression from true disease progression is a key challenge in interpreting imaging findings during cancer immunotherapy.
Related Concept Videos
Tumor Immunotherapy
Combination Therapies and Personalized Medicine
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
Targeted Cancer Therapies
There are several types of targeted therapies against...
Cytotoxic T Cells-mediated Immune Response
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
Cancer Therapies
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...

